Established in 2003, OncoMed Pharmaceuticals, Inc.,
brings together the four major players in the process of treating cancer and
blood diseases: patients, physicians, manufacturers, and manage-care
organizations. Ellen Scharaga, Senior Vice President of Operations, oversees
all facets of pharmacy, specialty injectable, and home infusion, including
government, Medicare Part D, HMO, and PPO programs, and directs pharmacy
dispensing and the call center. Typical of OncoMed’s top staff, Ms. Scharaga possesses
decades of experience in leadership positions in pharmaceuticals and home
infusion as well as business expertise.
Headquartered in New York, OncoMed maintains
licensing to deliver its specialized prescriptions in every state. The
company’s inventory includes numerous chemotherapy and bio-oncology medications
and limited-distribution pharmaceuticals. For physicians, OncoMed reduces
administrative time and lowers reimburse risk. Patients gain better access to
medications and care management, reducing out-of-pocket expenses. Manufacturers
increase their performance and credibility with OncoMed’s streamlined
distribution, including “just-in-time” capabilities providing life-saving
treatments. Managed care programs benefit through the care management and
bio-oncology pharmaceutical-distribution platform.
Compounding and mixing occur in a clean-room
environment supervised by oncology-certified pharmacists, who remain available
24/7 to assist in formulating optimal prescription plans. Packaged in
stability-ensured and temperature-sensitive containers, all orders arrive at
offices or homes with clearly marked order identification/patient numbers.
Ultimately, OncoMed and Ellen Scharaga endeavor to make life easier for
physicians, patients, manufacturers, and managed-care organizations, freeing
doctors to treat, patients to heal, manufacturers to produce, and manage-care
groups to manage care.